Index N and O National <strong>Health</strong> Reference Price List (NHRPL) National Pharmaceutical Product Index (NAPPI) 10, 49, 66, 96, 187 96-97, 185, 187 National Strategic Plan (NSP) 12, 14, 202, 206-207, 210, 242-244 Non-communicable Disease 105-107, 215, 229, 230, 245, 261, 271, 316 Occupational health 28, 52, 103, 107, 109, 111-112, 115-119, 207-209 Open enrolment 47, 48, 127 Out-of-pocket 37-38, 43-44, 55, 72, 75, 80-81, 84, 113, 119, 131, 146, 167, 184, 220, 316 P Prescribed Minimum Benefits (PMBs) 7, 10, 19, 23, 25-26, 43, 48-49, 52, 58-62, 64-65, 67-68, 73, 77, 80, 82, 97-98, 119, 125, 127, 130, 134, 144, 185-187, 202, 208, 271, 316 Primary <strong>Health</strong> Care (PHC) 37, 39, 44, 72, 77, 80, 82-83, 91, 93, 111, 115, 144, 176, 179-181, 185, 206, 218, 220, 224, 264, 281-284, 307, 321-326, 335-337 Primary <strong>Health</strong> Care Package 125 Public-Private Interactions (PPIs) 145, 152 Public-Private Partnerships (PPPs) 9, 11, 118, 135, 148, 151-153, 157, 201, 207-210 R Remunerative Work Outside the Public 142, 144-148, 165 Service (RWOPS) Risk Equalisation Fund (REF) 9-11, 19, 25, 47, 49, 58, 61-68, 79-80, 82, 89-90, 92-93, 97-98, 134, 186-187, 219, 243, 250, 254, 271, 316 Risk-pooling 48-49, 57-59, 61-63, 68, 73, 79, 82, 113 S Sexually Transmitted Infection (STI) 11-13, 21, 201-202, 206-207, 210, 218-219, 242, 257, 260, 283, 334, 336 Single Exit Price (SEP) 10, 21, 42, 128, 131-132, 134, 315 Statutory Return (SR) 64-65, 92-94 Stewardship 3, 4, 6-9, 11-12, 14-15, 306 T, U, V, W, X, Y, Z Traditional Healers 41, 44, 175, 177-178, 181-186, 190-198, 208-209, 215, 224, 282 Traditional Medicine 98, 175-176, 178, 180-181, 183, 185-186, 189-199 Tuberculosis (TB) 107, 108, 201, 202, 206-210, 218-219, 224, 235-239, 242, 244, 283, 319, 328- 329, 332, 336 Extremely Drug Resistant TB (XDR-TB) 206, 237 Multiple Drug Resistant TB (MDR-TB) 207, 235, 237 Uniform Patient Fee Schedule 96 Uninsured (public-sector dependent) population 220, 233, 282, 307, 311, 320-321, 323-324, 336-337 353
354
- Page 2 and 3:
South African Health Review 2007 LI
- Page 4:
Foreword The 12th edition of South
- Page 7 and 8:
12 Traditional and Complementary Me
- Page 9 and 10:
Other Funders for the Health System
- Page 11 and 12:
This response raises a number of qu
- Page 13 and 14:
ucts are currently sold without reg
- Page 15 and 16:
The authors conclude that mandatory
- Page 17 and 18:
servicing and inappropriate hospita
- Page 19 and 20:
systems is also critical; worrying
- Page 22 and 23:
Authors: Laetitia Rispel i Geoffrey
- Page 24 and 25:
Stewardship: Protecting the Public
- Page 26 and 27:
Stewardship: Protecting the Public
- Page 28 and 29:
Stewardship: Protecting the Public
- Page 30 and 31:
Stewardship: Protecting the Public
- Page 32 and 33:
Stewardship: Protecting the Public
- Page 34 and 35:
Stewardship: Protecting the Public
- Page 36:
Stewardship: Protecting the Public
- Page 39 and 40:
Introduction The importance of the
- Page 41 and 42:
diseases such as tuberculosis and t
- Page 43 and 44:
17 of 2002). This Act entirely repl
- Page 45 and 46:
(d) and any other matter relating t
- Page 47 and 48:
Year Act No. Title Objects 1997 90
- Page 49 and 50:
References 1 Department of Health.
- Page 52:
Purchasing of Health Care 33Pooling
- Page 55 and 56:
Introduction This chapter presents
- Page 57 and 58:
Medical schemes are the largest fin
- Page 59 and 60:
per person dependent on the public
- Page 61 and 62:
An increase in hospital expenditure
- Page 63 and 64:
private pharmacy do so for self-tre
- Page 65 and 66:
References 1 McIntyre D, Thiede M,
- Page 67 and 68:
Policy and legislative framework In
- Page 69 and 70:
Medical schemes and revenue collect
- Page 71 and 72:
There is evidence that when faced w
- Page 73 and 74:
are thus contributing factors to th
- Page 75 and 76:
Figure 2: Historic membership of me
- Page 77 and 78:
Solvency of the risk pools has beco
- Page 79 and 80:
Figure 4: 100 Proportion of risk be
- Page 81 and 82:
will retain that benefit for their
- Page 83 and 84:
There is a general sense (but often
- Page 85 and 86:
From a benefit design perspective t
- Page 87 and 88:
and towards competition based on ef
- Page 89 and 90:
37 Du Preez L. Registrar wants cura
- Page 91 and 92:
Introduction There has long been co
- Page 93 and 94:
an element of cream-skimming which
- Page 95 and 96:
Table 1: Distribution of health car
- Page 97 and 98:
isk equalisation mechanism were imp
- Page 99 and 100:
once the cost spiral in medical sch
- Page 101 and 102:
Revenue collection: Collecting orga
- Page 103 and 104:
Current debates A key area of ongoi
- Page 105 and 106:
References 1 Gluckman H. The Provis
- Page 108 and 109:
Authors: Patrick Matshidze i Lyn Ha
- Page 110 and 111:
Health Information Systems in the P
- Page 112 and 113:
Health Information Systems in the P
- Page 114 and 115:
Health Information Systems in the P
- Page 116 and 117:
Health Information Systems in the P
- Page 118 and 119:
Health Information Systems in the P
- Page 120 and 121:
Health Information Systems in the P
- Page 122 and 123:
Authors: Shahieda Adams i Reno Mora
- Page 124 and 125:
Health and Health Care in the Workp
- Page 126 and 127:
Health and Health Care in the Workp
- Page 128 and 129:
Health and Health Care in the Workp
- Page 130 and 131:
Health and Health Care in the Workp
- Page 132 and 133:
Health and Health Care in the Workp
- Page 134 and 135:
Health and Health Care in the Workp
- Page 136 and 137:
Health and Health Care in the Workp
- Page 138 and 139:
Health and Health Care in the Workp
- Page 140 and 141:
Health and Health Care in the Workp
- Page 142 and 143:
Author: Bettina Taylor i 8 Rationin
- Page 144 and 145:
Rationing of Medicines and Health C
- Page 146 and 147:
Rationing of Medicines and Health C
- Page 148 and 149:
Rationing of Medicines and Health C
- Page 150 and 151:
Rationing of Medicines and Health C
- Page 152 and 153:
Rationing of Medicines and Health C
- Page 154 and 155:
Rationing of Medicines and Health C
- Page 156 and 157:
Rationing of Medicines and Health C
- Page 158 and 159:
Health Care Delivery 139
- Page 160 and 161:
Authors: Haroon Wadee i Farzana Kha
- Page 162 and 163:
Human Resources for Health 9 Table
- Page 164 and 165:
Human Resources for Health 9 Table
- Page 166 and 167:
Human Resources for Health 9 source
- Page 168 and 169:
Human Resources for Health 9 Refere
- Page 170 and 171:
Authors: Shadrack Shuping i Sipho K
- Page 172 and 173:
Public-Private Partnerships 10 Alth
- Page 174 and 175:
Public-Private Partnerships 10 Tabl
- Page 176 and 177:
Public-Private Partnerships 10 Conc
- Page 178 and 179:
Authors: Thulani Matsebula i Michae
- Page 180 and 181:
Private Hospitals 11 Table 1: Priva
- Page 182 and 183:
Private Hospitals 11 Table 3: Distr
- Page 184 and 185:
Private Hospitals 11 Human resource
- Page 186 and 187:
Private Hospitals 11 Figure 3: 16 T
- Page 188 and 189:
Private Hospitals 11 Figure 4: 2 50
- Page 190 and 191:
Private Hospitals 11 Monitoring qua
- Page 192 and 193:
Private Hospitals 11 Recommendation
- Page 194 and 195:
Authors: Nceba Gqaleni i Indres Moo
- Page 196 and 197:
Traditional and Complementary Medic
- Page 198 and 199:
Traditional and Complementary Medic
- Page 200 and 201:
Traditional and Complementary Medic
- Page 202 and 203:
Traditional and Complementary Medic
- Page 204 and 205:
Traditional and Complementary Medic
- Page 206 and 207:
Traditional and Complementary Medic
- Page 208 and 209:
Authors: Myles Mander i Lungile Ntu
- Page 210 and 211:
Economics of the Traditional Medici
- Page 212 and 213:
Economics of the Traditional Medici
- Page 214 and 215:
Economics of the Traditional Medici
- Page 216 and 217:
Economics of the Traditional Medici
- Page 218 and 219:
Economics of the Traditional Medici
- Page 220 and 221:
Authors: Marion Stevens i Edina Sin
- Page 222 and 223:
HIV and AIDS, STI and TB in the Pri
- Page 224 and 225:
HIV and AIDS, STI and TB in the Pri
- Page 226 and 227:
HIV and AIDS, STI and TB in the Pri
- Page 228 and 229:
HIV and AIDS, STI and TB in the Pri
- Page 230 and 231:
HIV and AIDS, STI and TB in the Pri
- Page 232 and 233:
Indicators 213
- Page 234 and 235:
Authors: Candy Day i Andy Gray ii 1
- Page 236 and 237:
Health and Related Indicators 15
- Page 238 and 239:
Health and Related Indicators 15
- Page 240 and 241:
Health and Related Indicators 15 Ta
- Page 242 and 243:
Health and Related Indicators 15 Ta
- Page 244 and 245:
Health and Related Indicators 15 Ta
- Page 246 and 247:
Health and Related Indicators 15 Ta
- Page 248 and 249:
Health and Related Indicators 15 Th
- Page 250 and 251:
Health and Related Indicators 15 Ta
- Page 252 and 253:
Health and Related Indicators 15 Ta
- Page 254 and 255:
Health and Related Indicators 15 Tu
- Page 256 and 257:
Health and Related Indicators 15 Fi
- Page 258 and 259:
Health and Related Indicators 15 He
- Page 260 and 261:
Health and Related Indicators 15 Ta
- Page 262 and 263:
Health and Related Indicators 15 tr
- Page 264 and 265:
Health and Related Indicators 15 Fi
- Page 266 and 267:
Health and Related Indicators 15 He
- Page 268 and 269:
Health and Related Indicators 15 Fi
- Page 270 and 271:
Health and Related Indicators 15 Ta
- Page 272 and 273:
Health and Related Indicators 15 Ta
- Page 274 and 275:
Health and Related Indicators 15 He
- Page 276 and 277:
Health and Related Indicators 15 He
- Page 278 and 279:
Health and Related Indicators 15 Ta
- Page 280 and 281:
Health and Related Indicators 15 Nu
- Page 282 and 283:
Health and Related Indicators 15 He
- Page 284 and 285:
Health and Related Indicators 15 19
- Page 286 and 287:
Health and Related Indicators 15 He
- Page 288 and 289:
Health and Related Indicators 15 Ta
- Page 290 and 291:
Health and Related Indicators 15 No
- Page 292 and 293:
Health and Related Indicators 15 Ta
- Page 294 and 295:
Health and Related Indicators 15 Be
- Page 296 and 297:
Health and Related Indicators 15 He
- Page 298 and 299:
Health and Related Indicators 15 Fi
- Page 300 and 301:
Health and Related Indicators 15 He
- Page 302 and 303:
Health and Related Indicators 15 De
- Page 304 and 305:
Health and Related Indicators 15 Ma
- Page 306 and 307:
Health and Related Indicators 15 Ea
- Page 308 and 309:
Health and Related Indicators 15 Fr
- Page 310 and 311:
Health and Related Indicators 15 Ga
- Page 312 and 313:
Health and Related Indicators 15 Kw
- Page 314 and 315:
Health and Related Indicators 15 He
- Page 316 and 317:
Health and Related Indicators 15 Li
- Page 318 and 319:
Health and Related Indicators 15 Mp
- Page 320 and 321:
Health and Related Indicators 15 No
- Page 322 and 323: Health and Related Indicators 15 No
- Page 324 and 325: Health and Related Indicators 15 We
- Page 326 and 327: Health and Related Indicators 15
- Page 328 and 329: Health and Related Indicators 15 Ta
- Page 330 and 331: Health and Related Indicators 15 Ta
- Page 332 and 333: Health and Related Indicators 15 He
- Page 334 and 335: Health and Related Indicators 15 He
- Page 336 and 337: Health and Related Indicators 15 Pu
- Page 338 and 339: Health and Related Indicators 15 Ta
- Page 340 and 341: Health and Related Indicators 15 Di
- Page 342 and 343: Health and Related Indicators 15 He
- Page 344 and 345: Health and Related Indicators 15 He
- Page 346 and 347: Health and Related Indicators 15 In
- Page 348 and 349: Health and Related Indicators 15 Ta
- Page 350 and 351: Health and Related Indicators 15 In
- Page 352 and 353: Health and Related Indicators 15 Ty
- Page 354 and 355: Health and Related Indicators 15 Ty
- Page 356 and 357: Health and Related Indicators 15 Ty
- Page 358 and 359: Health and Related Indicators 15 Ch
- Page 360 and 361: Health and Related Indicators 15 MD
- Page 362 and 363: Health and Related Indicators 15 St
- Page 364 and 365: Glossary AFA AIDS ALP AMA ANC ART A
- Page 366 and 367: Glossary KZN LFS LIMS LP LPP MAR MC
- Page 368 and 369: Glossary SAPC SARS SASIM SASSA SEP
- Page 370 and 371: Index A Acts (Legislation and Bills